117 results
Page 2 of 6
S-8
EX-4.2
qtts m3v6x
22 May 24
Registration of securities for employees
4:33pm
S-8
EX-4.3
es19kurdi1jk 4s8
22 May 24
Registration of securities for employees
4:33pm
S-8
EX-4.6
wgfolexrei047 s8i
22 May 24
Registration of securities for employees
4:33pm
S-8
EX-4.5
dnp7ovu8g0o5u
22 May 24
Registration of securities for employees
4:33pm
S-8
EX-4.4
jqx 7y99xv
22 May 24
Registration of securities for employees
4:33pm
8-K
EX-99.1
ocbgy h83bxja
24 Apr 24
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:05pm
424B5
szlpdm
1 Mar 24
Prospectus supplement for primary offering
4:13pm
8-K
EX-1.1
ea3a 7nsh44t8muhfdxi
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
424B5
dc3xf9q7dik4vn
27 Feb 24
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
99rh 3oze2
7 Feb 24
Viking Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
4:09pm
8-K
EX-99.1
omwkri8n
25 Oct 23
Viking Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:24pm
S-3ASR
EX-4.2
woaxn wtfypqjnowvr
26 Jul 23
Automatic shelf registration
5:26pm
S-3ASR
srs8ogx87 xtti
26 Jul 23
Automatic shelf registration
5:26pm